Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 1829-1835

  Dahlstrand, Hanna ^a   Dahlgren, Liselotte ^a   Lindquist, David ^a   Munck Wikland, Eva ^a   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Head and neck cancer; HPV; Tonsillar cancer

Indexed keywords

ANEUPLOIDY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME ABERRATION; GENETIC STABILITY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; REVIEW; SWEDEN; TONSIL CANCER; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TONSILLAR NEOPLASMS;

EID: 3242669053     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM and Jansen KU: A controlled trial of human papillomavirus type 16 vaccine. N Engl J Med 347: 1645-1651, 2002.
2. Lehtinen M, Malm C, Apter D, Heikkilä R, Heino P, Rimpilä K, Ziliacus R and Paavonen J: Preventive vaccines against papillomavirus and cervical cancer will soon enter routine practice. Läkartidningen 100: 3408-3412, 2003.
3. zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288: 9 F55-78, 1996.
4. zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 111: 581-587, 1999.
5. de Villiers EM: Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allografts recipients. Int J Cancer 73: 356-361, 1997.
6. Snijders PJF, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB and Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral aetiology. Int J Cancer 51: 845-850, 1992.
7. Snijders PJF, Scholes AGM, Hart A, Jones AS, Vaughan ED, Woolgar JA, Meijer CJLM, Walboomers JMM and Field JK: Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 66: 464-469, 1996.
8. Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer; clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304, 2000.
9. Nathanson A, Lewin F, Lind M, Lundgren J and Strander H: Huvudhals och esofaguscancer Onkologisk Centrum Stockholm-Gotland, 1999.
10. Bray F, Sankila R, Ferlay J and Parkin DM: Estimates of cancer incidence and mortality in Europe 1995. Eur J Cancer 38: 99-166, 2002.
11. Decker J and Goldstein J: Risk factors in head and neck cancer, New Engl J Med 306: 1151-1155, 1982.
12. Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P and Lefebvre JL: Cancer of the oropharynx. Crit Rev Oncol Hematol 41: 101-122, 2002.
13. Gillison ML, Koch WM and Shah KV: Human papillomaviruses-associated head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 11: 191-199, 1999.
14. de Villiers EM: Viruses in cancers of the head and neck. Adv Otolaryngol 46: 116-123, 1991.
15. Zeng Y, Zhang LG, Li HY, Jan MG, Zhang Q, Wu YC, Wang YS and Su GR: Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City China. Int J Cancer 29: 139-141, 1982.
16. Gissmann L, Diehl V, Schultz-Coulon HJ and zur Hausen H: Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J Virol 44: 393-400, 1982.
17. Syrjanen K, Syrjanen S, Lamberg M, Pyrhönen S and Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12: 418-424, 1983.
18. de Villiers EM, Weidauer H, Otto H and zur Hausen H: Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36: 575-578, 1985.
19. Naghashfar Z, Sawada E, Kutcher MJ, Swancar J, Gupta J, Daniel R, Kashima H, Woodruff JD and Shah K: Identification of genital tract papillomaviruses HPV-6 and HPV-16 in warts of the oral cavity. J Med Virol 17: 313-324, 1985.
20. Alani RM and Munger K: Human papillomaviruses and associated malignancies J Clin Oncol 16: 330-337, 1998.
21. Gillison ML, Koch WM, Caoibe RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
22. Gillison ML and Shah KV: Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role of human papillomavirus in a subset of head and neck cancers Curr Opin Oncol 13: 183-188, 2001.
23. Mork J, Lie AK, Ġlattre E, Hallmans G, Jellim E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M and Dillner J: Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Engl J Med 344: 1125-1131, 2001.
24. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H and Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinoma lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13, 1998.
25. Paz IB, Cook N, Odom-Maryon T, Xie Y and Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer: an association of HPV with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604, 1997.
26. Shah K and Howley PM: Papillomaviruses In: Fields BN, Knipe DM, Chanoch RM, Hirsch MS, Melnick JL, Monath TP and Roizman B (eds): Virology 2nd edition, pp1651-1676, 1990.
27. Schneider A and Koutsky L: Natural history and epidemiological features of genital HPV infection. In: The Epidemiology of Cervical Cancer and Human Papillomavirus. Eds. Munoz N, Bosch FX, Shah KV and Meheus A, Lyon IARC Scientific Publications, No 119: 25-52, 1992.
28. van den Brule A, Snijders P, Meijer C and Walboomers J: PCR-based detection of genital HPV genotypes: an update and future perspectives. Papillomavirus Report 4: 95-99, 1993.
29. Higgins G, Uzelin D, Phillips G, Pieterse S and Burell C: Differing characteristics of human papillomavirus RNA positive and RNA negative anal carcinomas. Cancer 68: 561-567, 1991.
30. Heino P, Eklund C, Fredriksson-Shanazarian V, Goldman S, Scheller J and Dillner J: Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 87: 437-440, 1995.
31. Snijders, PJF, van den Brule AJC, Meijer CJ and Walboomers JM: Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Top Microbiol Immunol 186: 177-198, 1994.
32. Syrjanen SM and Syrjanen KJ: New concepts on the role of human papillomavirus in cell regulation. Ann Med 31: 175-187, 1999.
33. Heidari S, Krausewicz N, Kalantari M, Vlastos A, Griffin BE and Dalianis T: Persistence and tissue distribution of DNA in mice inoculated with polyoma VP1 pseudocapsid complexes or polyomavirus. J Virol 74: 11963-11965, 2000.
34. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissman L, Lowy DR and Schiller JT: Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67: 6929-6936, 1993.
35. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M and Dalianis T: Human papillomavirus type 16 is episomal and a high viral load is correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158, 2002.
36. Mellin H: Doctoral thesis; Human Papillomavirus in Tonsillar Cancer, Karolinska Institute, 2002.
37. de Roda Husman AM, Walboomers JM, van der Brule AJ, Meijer CJ and Sneijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J General Virol 76: 1057-1062, 1995.
38. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavnick JN, Berkhout RJ, Vermeer BJ, Jebbink MF and Smits HL: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42: 265-279, 1993.
39. Wilczynski SP, Lin BT, Xie Y and Paz IB: Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 152: 145-156, 1998.
40. Klussmann JP, Weissenborn SJ, Weiland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ and Fuchs PG: Prevalence, distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
41. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB and Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232-235, 2001.
42. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, McGovern R, Weaver AL, Persing D and Kasperbauer JL: Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8: 1093-1100, 2002.
43. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Hadad K, Björnestå hl L, Lindholm J, Munck-Wikland E, Auer G, Ried T and Dalianis T: Comparative genomic hybridization (CGH) analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus (HPV) positive and negative tumors. Int J Cancer 107: 244-249, 2003.
44. Reithdorf S, Friedrich RE, Ostwald C, Barten M, Gogacz P, Gundlach KK, Schlechte H, Bregenzer T, Reithdorf L and Loning T: p3 mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 26: 315-321, 1997.
45. Friesland S, Mellin H, Dalianis T, Munck-Wikland E and Lewensohn R: Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - relation to radiotherapy response and survival. Anticancer Res 21: 529-534, 2001.
46. Friesland S, Fernberg JO, Lundell G, Munck-Wikland E, Strander H and Lewensohn R: Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: A retrospective analysis of the Radiumhemmet data, 1980-1995. Int J Radiat Onc Biol Physics 45: 1259-1266, 1999.
47. Mellin H, Friesland S, Auer G, Dalianis T and Munck-Wikland E: Human papillomavirus and DNA ploidy in tonsillar cancer-correlation to prognosis. Anticancer Res 23: 2821-2828, 2003.
48. Rihet S, Lorenzato M and Clavel C: Oncogenic human papillomaviruses and ploidy in cervical lesions. J Clin Pathol 49: 892-896, 1996.
49. Lorenzato M, Clavel C, Masure M, Nou JM, Bouttens D, Evrard G, Bory JP, Maugard B, Quereux C and Birembaut P: DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions. J Pathol 194: 171-176, 2001.
50. Skyldberg B, Fujioka K, Hellström AC, Sylven L, Moberger B and Auer G: Human papillomavirus infection, centrosome aberration and genetic stability in cervical lesions. Mod Pathol 14: 279-284, 2001.